{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:34:56Z","timestamp":1788186896701,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008002","name":"Vancouver Coastal Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chew Wei Memorial Chair in Gynecologic Oncology"},{"name":"Vancouver General Hospital Foundation"},{"name":"Miller-Mindell Fellowship"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1136\/ijgc-2023-005149","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:30:53Z","timestamp":1708605053000},"page":"544-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-9102","authenticated-orcid":false,"given":"Amy","family":"Jamieson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Grube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-8250","authenticated-orcid":false,"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6003-485X","authenticated-orcid":false,"given":"Jessica N","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-005149_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-005149_bb0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2023-005149_bb0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"WHO classification of female genital tumors","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1136\/ijgc-2023-005149_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211035959","article-title":"The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer","volume":"13","author":"Jamieson","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.6004\/jnccn.2022.7096","article-title":"Molecular profiling of endometrial cancer from TCGA to clinical practice","volume":"21","author":"Jamieson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2023-005149_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2022.12.019","article-title":"The continuing evolution of endometrial carcinoma molecular classification: risk stratification within the no specific molecular profile (NSMP) subtype","volume":"171","author":"Jamieson","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0040","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the promise molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0045","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0050","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2023-005149_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2023-005149_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of promise: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-005149_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1136\/ijgc-2023-005149_bb0070","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"P53 immunohistochemistry is an accurate surrogate for Tp53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J Pathol"},{"key":"10.1136\/ijgc-2023-005149_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ygyno.2023.05.073","article-title":"Harmonized molecular classification; assessment of a single-test promise NGS tool","volume":"175","author":"Jamieson","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/ijgc-2020-002256","article-title":"P53Abn endometrial cancer: understanding the most aggressive endometrial cancers in the era of molecular classification","volume":"31","author":"Jamieson","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005149_bb0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2022.01.007","article-title":"Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment","volume":"164","author":"Leon-Castillo","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0090","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41379-022-01165-w","article-title":"Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification","volume":"35","author":"Thompson","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2023-005149_bb0095","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1158\/1078-0432.CCR-23-1397","article-title":"Clinical behavior and molecular landscape of stage I P53-abnormal low-grade Endometrioid endometrial Carcinomas","volume":"29","author":"Jamieson","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2023-005149_bb0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2023.01.025","article-title":"Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer","volume":"170","author":"Jamieson","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005149_bb0110","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2022.02.001","article-title":"Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"10.1136\/ijgc-2023-005149_bb0125","author":"National Comprehensive Cancer Network (NCCN)","year":"2023","journal-title":"Inc NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Uterine Cancer Version 2.2023"},{"key":"10.1136\/ijgc-2023-005149_bb0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PGP.0000000000000674","article-title":"Equivalent survival of P53 mutated endometrial endometrioid carcinoma grade 3 and endometrial serous carcinoma","volume":"40","author":"Brett","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1136\/ijgc-2023-005149_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Rios-Doria","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/annonc\/mdx753","article-title":"Clinical consequences of ppfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer","volume":"29","author":"de Boer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0145","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor Interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2023-005149_bb0150","doi-asserted-by":"crossref","first-page":"836","DOI":"10.5858\/arpa.2015-0220-OA","article-title":"Interobserver variability in the diagnosis of uterine high-grade endometrioid carcinoma","volume":"140","author":"Thomas","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1136\/ijgc-2023-005149_bb0155","article-title":"Distant recurrence in a patient with polyp-confined stage IA serous endometrial carcinoma treated with adjuvant chemotherapy: a case report and review of literature","volume":"31","author":"Welp","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2023-005149_bb0160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/ijgc-2020-001379","article-title":"Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium","volume":"30","author":"Nasioudis","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005149_bb0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2022.09.025","article-title":"Adjuvant therapy in women with early stage uterine serous carcinoma: a multi-institutional study","volume":"167","author":"Kurnit","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005149_bb0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2022.01.025","article-title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-005149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:29:40Z","timestamp":1753234180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24013628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1048891X24013628"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-005149","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-005149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}